Evidence map›Paper›PMID 39975185›Full record

ArticlebioRxiv : the preprint server for biology2025

A Cooperative Model for Symmetric Ligand Binding to Protein Fibrils.

Matthew S Smith, William F DeGrado, Michael Grabe, Brian K Shoichet

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Matthew S SmithDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. UCSF Genentech Hall Box 2280, 600 16th St Rm 518, San Francisco, CA 94158.ORCID 0009-0008-8481-2538
William F DeGradoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. UCSF Genentech Hall Box 2280, 600 16th St Rm 518, San Francisco, CA 94158.ORCID 0000-0003-4745-263X
Michael GrabeDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. UCSF Genentech Hall Box 2280, 600 16th St Rm 518, San Francisco, CA 94158.ORCID 0000-0003-3509-5997
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA. UCSF Genentech Hall Box 2280, 600 16th St Rm 518, San Francisco, CA 94158.ORCID 0000-0002-6098-7367

Funding

Development and Testing of New Computational Methods for Ligand Discovery and MechanismR35GM122481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian K Shoichet · 2017 to 2026
$8.5M
NIGMS NIH HHS R35 GM122481
6 · The paper itself

Abstract

A hallmark of neurodegenerative diseases like Alzheimer's Disease (AD) and chronic traumatic encephalopathy (CTE) is the presence of toxic protein aggregates in neurons. In AD and CTE specifically, the protein tau forms insoluble fibrils that are hundreds of nanometers in length. Intriguingly, recent experimental structures suggest that tau ligands like the disaggregator EGCG and positron emission tomography (PET) tracers like GTP-1 and MK-6240 bind to tau fibrils in long stacks reflecting the symmetry of the protein across many binding sites. In these stacks, each ligand makes more contact with its symmetry mates than it does with the protein. To interpret the binding of these molecules and new ligands, we must understand the effects of the cooperativity between sites and the entropy coming from the number of sites. Here, we investigate a nearest-neighbors model of cooperativity and use statistical mechanics to derive binding isotherms for saturation and competition experiments. This model allows us to relate measured

Identifiers

PMID39975185
PMCPMC11838254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.